共 322 条
[41]
Rosenquist R(1994)Comparison of protein synthesis profiles in chronic lymphocytic leukaemia cells and B-lymphocytes from peripheral blood, cord blood and tonsil Experientia 50 493-52
[42]
Bokelmann I(2009)Acquired mutations in TET2 are common in myelodysplastic syndromes Nat Genet 41 838-67
[43]
Mahlknecht U(2009)Mutation in TET2 in myeloid cancers N Engl J Med 360 2289-38
[44]
Inoue S(2010)Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies Ann Hematol 89 643-9
[45]
Walewska R(2010)Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell 18 553-5
[46]
Dyer MJ(2011)TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis Cancer Cell 20 25-71
[47]
Cohen GM(2014)TET2 as an epigenetic master regulator for normal and malignant hematopoiesis Cancer Sci 105 1093-8
[48]
Stamatopoulos B(2011)Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors Blood 118 2551-34
[49]
Meuleman N(2011)Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice Proc Natl Acad Sci U S A 108 14566-65
[50]
De Bruyn C(2014)Characterization of acute myeloid leukemia based on levels of global hydroxymethylation Blood 124 1110-7